- Resistance to degradation in the gastrointestinal tract
Lets dive deeper. Watch full webinar - #GLP1 #WeightLoss #HealthIreland #ObesityAwareness #WeightManagement #HealthyLiving #Motivation #WellnessJourney #BodyPositive #WeightLossJourney | Motivation Weight Management Clinics
The Injection (Subcutaneous) - Dosing: Once weekly - Bioavailability: ~100% (bypasses GI tract) - Weight loss in trials: Up to 22% at 36 weeks - Best for: Patients seeking maximum efficacy, comfortable with self-injection The Pill (Oral) - Dosing: Once daily (taken on an empty stomach, similar to Rybelsus) - Bioavailability: Lower than SC (relies on SNAC absorption technology) - Weight loss in trials: Up to 13.1% at 12 weeks (Phase 1 short duration) - Best for: Injection-averse patients, early treatment, maintenance, broader access The oral formulation will almost certainly deliver less weight loss than the subcutaneous version at equivalent treatment durations
The easy-to-use pump bottle makes application a breeze, allowing you to incorporate this powerful lotion into your daily skincare regimen effortlessly
M., Rousseau, F., Schymkowitz, J
;Resize=(1280,712))
